Report copyright - SUMMARY OF CHANGES - Protocol NCI Protocol # 8348 Current ... · NCI Protocol: 8348 DF/HCC Protocol: 09-293 Phase I/II Cediranib/Olaparib in Recurrent Ovarian or Triple-Negative Breast
Please pass captcha verification before submit form